Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$0.36 - $0.61 $110,890 - $187,897
308,028 New
308,028 $120,000
Q1 2023

May 15, 2023

SELL
$2.05 - $2.87 $446,610 - $625,255
-217,859 Reduced 34.86%
407,100 $928,000
Q4 2022

Feb 14, 2023

BUY
$2.06 - $3.47 $148,114 - $249,493
71,900 Added 13.0%
624,959 $1.35 Million
Q3 2022

Nov 14, 2022

BUY
$2.6 - $5.12 $77,480 - $152,576
29,800 Added 5.7%
553,059 $1.58 Million
Q2 2022

Aug 15, 2022

BUY
$2.19 - $3.98 $820,860 - $1.49 Million
374,822 Added 252.51%
523,259 $1.3 Million
Q1 2022

May 16, 2022

BUY
$3.28 - $7.12 $486,873 - $1.06 Million
148,437 New
148,437 $568,000

Others Institutions Holding ME

About 23andMe Holding Co.


  • Ticker ME
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 259,768,000
  • Market Cap $857M
  • Description
  • 23andMe Holding Co. operates as a consumer genetics testing company. It operates through two segments, Consumer & Research Services and Therapeutics. The Consumer & Research Services segment provides a suite of genetic reports, including information on customers' genetic ancestral origins, personal genetic health risks, and chances of pa...
More about ME
Track This Portfolio

Track Schonfeld Strategic Advisors LLC Portfolio

Follow Schonfeld Strategic Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.